A researcher with interests in the early detection and progression of colorectal and other gastrointestinal cancers will join the Clinical Research Division this month.
Dr. William Grady, currently an assistant professor of medicine at Vanderbilt University Medical Center in Nashville, Tenn., studies the genetic abnormalities associated with gastrointestinal cancers. One of his research interests is to develop DNA-based tests to detect colorectal cancer in individuals at high risk for the disease. Grady also has developed a mouse-model system for studying gastrointestinal-cancer development.
Dr. Fred Appelbaum, director of the Clinical Research Division, said Grady brings great strengths to the division as a whole and to the center's expanding solid-tumor program.
"Bill has created an animal model that reliably mimics human disease, which promises to lead to greater understanding of how gastrointestinal cancer develops and progresses," he said. "It will also aid in the search for effective new treatments."
Grady received a medical degree from the University of Michigan Medical School and completed his residency at the University of Washington. He was a gastroenterology fellow at the University of Michigan and at Case Western Reserve University in Cleveland.